Changeflow GovPing Pharma & Healthcare Intradermal Acupuncture Ocular Surface Facial P...
Routine Notice Added Final

Intradermal Acupuncture Ocular Surface Facial Paralysis

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

The NIH has registered a clinical trial (NCT07537426) examining the efficacy of intradermal acupuncture for treating ocular surface diseases following intractable facial paralysis. The randomized controlled trial will compare active acupuncture intervention against sham-needle placebo, with the primary endpoint measured by Ocular Surface Disease Index score reduction.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document registers a randomized controlled clinical trial investigating whether intradermal acupuncture effectively reduces ocular surface disease symptoms in patients with intractable peripheral facial paralysis. Researchers will compare active intradermal acupuncture treatment against a sham intradermal acupuncture placebo, measuring outcomes using the Ocular Surface Disease Index (OSDI) scoring system. The trial enrollment status, interventions, conditions (Bell's Palsy, Ocular Surface Disease), and estimated completion date are recorded for transparency and public access.

Healthcare providers and clinical investigators should note this represents a prospective therapeutic trial using acupuncture as an investigative intervention. The sham-controlled design indicates scientific rigor appropriate for generating publishable efficacy data.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis

N/A NCT07537426 Kind: NA Apr 17, 2026

Abstract

The purpose of this study is to explore the clinical efficacy of intradermal acupuncture in the treatment of ocular surface diseases after Intractable Facial Paralysis, and to seek effective and convenient treatment for ocular surface diseases after intractable peripheral facial paralysis. The main question it aims to answer is : Will the intradermal acupuncture intervention effectively reduce the OSDI score ? The researchers compared the intradermal acupuncture with the placebo-needle to observe whether the intradermal acupuncture could better improve the symptoms.

Conditions: Facial Paralysis, Peripheral, Bell's Palsy, Ocular Surface Disease

Interventions: Intradermal acupuncture treatment, Sham intradermal acupuncture

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 17th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07537426

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical research Medical treatment
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!